NCT00311389View on ClinicalTrials.gov

A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Glaucoma, Open-angleOcular Hypertension
Interventions
DRUG

Travoprost 0.004%/Timolol maleate 0.5% ophthalmic solution

Investigational ophthalmic solution intended for the treatment of open-angle glaucoma or ocular hypertension

DRUG

Latanoprost 0.005%/Timolol 0.005% ophthalmic solution

Commercially marketed ophthalmic solution intended for the treatment of open-angle glaucoma or ocular hypertension

Trial Locations (1)

Unknown

European Facilitiies, Puurs

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY